Nymox Pharmaceutical Corporation DPO Ratio 2011-2026 | NYMX

Annual DPO Ratio Nymox Pharmaceutical Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	2.41 K	4.19 K	3.12 K	1.04 K	1.27 K	807

All numbers in USD currency

Maximum	Minimum	Average
4.19 K	807	2.14 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	5.06 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	5.24 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Coherus BioSciences CHRS	507	$ 1.63	-	$ 191 M	USA
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	31.7	$ 17.3	-	$ 809 M	USA
Autolus Therapeutics plc AUTL	9.57	$ 1.59	-	$ 423 M	Britain
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Compugen Ltd. CGEN	82.7	$ 3.03	-	$ 283 M	Israel
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Enlivex Therapeutics Ltd. ENLV	193	$ 0.73	-	$ 33.4 M	Israel
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	133	$ 21.57	-	$ 2.74 B	USA
Fennec Pharmaceuticals FENC	894	$ 9.24	-	$ 264 M	USA
Esperion Therapeutics ESPR	7.93 K	$ 3.12	-	$ 649 M	USA
Eton Pharmaceuticals ETON	74.3	$ 29.96	-	$ 806 M	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
Exelixis EXEL	148	$ 51.1	-	$ 13.9 B	USA